Unlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
Delivering groundbreaking therapies for autoimmune diseases & cancer.
Combining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
George Medicines is an innovative late-stage drug development company focused on the large, expanding and underserved market for the management of non-communicable diseases (NCDs)
Targeting long non-coding RNAs for next generation cancer therapies
Harnessing the power of bariatric surgery in Type 2 diabetes treatment with a non-absorbable polymer
Developing the next generation of CAR-T cell therapies to treat solid cancers
High Quality Serum for Biochemistry Analysis: A proprietary blood collection tube rapidly providing high quality serum for analysis from all bloods including anti-coagulated.
Ena Respiratory is a biotechnology company aiming to transform the treatment and prevention of respiratory infections. The company initial focus is to target respiratory infections in patients with asthma and COPD.
Osprey Medical’s DyeVert™ Plus System reduces contrast media in order to make angiography safer for Chronic Kidney Disease (CKD) patients.
Developing antibiotic therapy for cystic fibrosis
Developing innovative DNA sequencing technology
